Product Information

BROMPHEN-PSE-DM 2-30-10 MG/5 ML is a generic product labeled by Eywa Pharma Inc, priced at $0.0714 per ML under NDC 71930002643. Its NADAC has been published 296 times since Dec 23, 2020.

FDA first approved this application on Jun 16, 2020. Its Orange Book therapeutic-equivalence code is AA.

BROMPHEN-PSE-DM 2-30-10 MG/5 ML

Brompheniramine maleate, pseudoephedrine hydrochloride,
$0.0714per ML

Strength

2; 10; 30 mg/5mL; mg/5mL; mg/5mL

Manufacturer

Eywa Pharma Inc

NDC

71930002643

Classification

Generic

Dosage Form

SYRUP

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211170

FDA Approved

6/16/2020

TE Code

AA

On Market Since

6/26/2020

Pharmacological Classes

Adrenergic alpha-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has been published 296 times since Dec 23, 2020, and over the history we have for it it has risen 17.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0714 per ML
All-time high$0.1053 (Dec 11, 2024)
All-time low$0.0503 (Aug 17, 2022)
52-week high$0.0876
52-week low$0.0709
Median price$0.0730
Average price$0.0744
Largest weekly change+26.0% (Mar 23, 2022)
Weeks tracked296
Tracking sinceDec 23, 2020

Price History

1W

-1.7%

1M

-1.7%

3M

-0.8%

6M

-2.4%

1Y

-18.5%

3Y

-8.7%

5Y

+22.4%

All

+17.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Brompheniramine maleate, pseudoephedrine hydrochloride, market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

The current National Average Drug Acquisition Cost (NADAC) for BROMPHEN-PSE-DM 2-30-10 MG/5 ML, manufactured by Eywa Pharma Inc, is $0.0714 per ML (NDC 71930002643), effective Aug 19, 2026.

How has the price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML changed over time?

Over the history we have for it, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has risen 17.6%. It has been tracked across 296 weekly CMS publications since Dec 23, 2020.

What are the highest and lowest recorded NADAC prices for BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

Since Dec 23, 2020, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has ranged from a low of $0.0503 (Aug 17, 2022) to a high of $0.1053 (Dec 11, 2024), with a median of $0.0730 per ML.

Are there cheaper alternatives to BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

No other NADAC-published product currently shares the active ingredient and strength of BROMPHEN-PSE-DM 2-30-10 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

BROMPHEN-PSE-DM 2-30-10 MG/5 ML (NDC 71930002643) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.